Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still no effective vaccines against many viruses. New structural insights into the viral envelope, protein conformation, and antigenic epitopes can guide the design of novel vaccines against challenging viruses such as human immunodeficiency virus (HIV), hepatitis C virus, enterovirus A71, and dengue virus. Recent studies demonstrated that applications of this structural information can solve some of the vaccine conundrums. This review focuses on recent advances in structure-based vaccine design, or structural vaccinology, for novel and innovative viral vaccine design
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still n...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Novel immunological tools for efficient diagnosis and treatment of emerging infections are urgently...
Despite improving treatment methods and therapeutic options, hepatitis C virus (HCV) remains a major...
Novel immunological tools for efficient diagnosis and treatment of emerging infections are urgently ...
The use of atomic-level information in the design of immunogens has created new candidate vaccines a...
The genomic era has completely changed the vaccinology landscape. Starting from the genomic repertoi...
Despite recent advances in therapeutic options, hepatitis C virus (HCV) remains a severe global dise...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Introduction: The development of a human immunodeficiency virus 1 (HIV-1) vaccine remains a formidab...
Vaccines can prevent many millions of illnesses against infectious diseases and save numerous lives ...
Proteins are fundamental components in biological systems and crucial for a variety of biological fu...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still n...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Novel immunological tools for efficient diagnosis and treatment of emerging infections are urgently...
Despite improving treatment methods and therapeutic options, hepatitis C virus (HCV) remains a major...
Novel immunological tools for efficient diagnosis and treatment of emerging infections are urgently ...
The use of atomic-level information in the design of immunogens has created new candidate vaccines a...
The genomic era has completely changed the vaccinology landscape. Starting from the genomic repertoi...
Despite recent advances in therapeutic options, hepatitis C virus (HCV) remains a severe global dise...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Introduction: The development of a human immunodeficiency virus 1 (HIV-1) vaccine remains a formidab...
Vaccines can prevent many millions of illnesses against infectious diseases and save numerous lives ...
Proteins are fundamental components in biological systems and crucial for a variety of biological fu...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...